SCHEMBL6487073

SCHEMBL6487073

CCc1cc(Cc2ccc([C]=O)cc2)c2ccccc2n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADAM17 P78536 4/20 0.45
KDM4E B2RXH2 1/20 0.38
KMT2A Q03164 2/20 0.38
MEN1 O00255 1/20 0.38
ELANE P08246 1/20 0.38
LMNA P02545 1/20 0.36
TP53 P04637 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
NPC1 O15118 1/20 0.35
POLB P06746 1/20 0.35
AGTR1 P30556 2/20 0.35
TNKS2 Q9H2K2 1/20 0.35
AGTR2 P50052 1/20 0.35
TLR8 Q9NR97 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
GAA P10253 1/20 0.34
CYP2D6 P10635 1/20 0.34
MAPT P10636 1/20 0.34
CYP2C9 P11712 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10733967 0.85 ADAM17 (0.46) ADAM17KDM4EKMT2AMEN1ELANE
SCHEMBL3964963 0.83 CYP1A2 (0.50) ADAM17RXFP1CYP1A2SMN1; SMN2
SCHEMBL6487084 0.82 ADAM17 (0.46) ADAM17KDM4EKMT2AMEN1ELANE
SCHEMBL6630276 0.81 ADAM17 (0.45) ADAM17KDM4EKMT2AMEN1ELANE
SCHEMBL4058443 0.81 ADAM17 (0.54) ADAM17KDM4EKMT2AMEN1LMNA
SCHEMBL4449639 0.79 ADAM17 (0.52) ADAM17KDM4ELMNATP53RXFP1
SCHEMBL4051716 0.79 ADAM17 (0.42) ADAM17KDM4EKMT2AMEN1ELANE
SCHEMBL9184895 0.79 KDM4E (0.50) ADAM17KDM4EKMT2AMEN1ELANE
SCHEMBL6220789 0.77 ADAM17 (0.53) ADAM17KDM4EKMT2AMEN1NPC1
SCHEMBL6628750 0.75 ADAM17 (0.46) ADAM17KDM4EKMT2ALMNATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6962938-B2 Spiro-cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α converting enzyme (TACE) BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2005-11-08 US disclosed
US-6720329-B2 ANTIINFLAMMATORY AGENTS BRISTOL-MYERS SQUIBB PHARMA 2004-04-13 US disclosed
EP-1373199-A4 SPIRO-CYCLIC BETA-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES AND TNF-ALPHA CONVERTING ENZYME (TAGE) BRISTOL MYERS SQUIBB PHARMA CO (US) 2004-04-07 EP disclosed
EP-1373199-A2 SPIRO-CYCLIC BETA-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES AND TNF-ALPHA CONVERTING ENZYME (TAGE) Bristol-Myers Squibb Pharma Company (US) 2004-01-02 EP disclosed
WO-2002074738-A2 SPIRO-CYCLIC BETA-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES AND TNF-ALPHA CONVERTING ENZYME (TAGE) BRISTOL-MYERS SQUIBB COMPANY (US) 2002-09-26 WO disclosed